Jin‐Min Guo

539 total citations
23 papers, 425 citations indexed

About

Jin‐Min Guo is a scholar working on Neurology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Jin‐Min Guo has authored 23 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Neurology, 5 papers in Molecular Biology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Jin‐Min Guo's work include Vagus Nerve Stimulation Research (3 papers), Eicosanoids and Hypertension Pharmacology (3 papers) and Alcohol Consumption and Health Effects (3 papers). Jin‐Min Guo is often cited by papers focused on Vagus Nerve Stimulation Research (3 papers), Eicosanoids and Hypertension Pharmacology (3 papers) and Alcohol Consumption and Health Effects (3 papers). Jin‐Min Guo collaborates with scholars based in China and United States. Jin‐Min Guo's co-authors include Aijun Liu, Ding‐Feng Su, Jawahar L. Mehta, Ding‐Feng Su, Pu Xu, Jun Cai, Pu Zang, Junli Duan, Wei Wang and Ying Li and has published in prestigious journals such as European Heart Journal, Journal of Cerebral Blood Flow & Metabolism and European Journal of Pharmacology.

In The Last Decade

Jin‐Min Guo

21 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jin‐Min Guo China 10 147 106 78 76 75 23 425
Xiu‐Juan Ma China 14 313 2.1× 91 0.9× 40 0.5× 114 1.5× 90 1.2× 21 661
Michael M. Yeboah United States 9 218 1.5× 223 2.1× 61 0.8× 92 1.2× 33 0.4× 12 477
Kamila C. Silva Brazil 13 218 1.5× 87 0.8× 44 0.6× 60 0.8× 104 1.4× 14 620
Youguang Gao China 13 306 2.1× 82 0.8× 78 1.0× 45 0.6× 90 1.2× 19 736
Kiyotaka Hoshiai Japan 9 197 1.3× 63 0.6× 38 0.5× 86 1.1× 133 1.8× 24 489
Shinsuke Kiritoshi Japan 6 205 1.4× 54 0.5× 35 0.4× 60 0.8× 124 1.7× 6 575
Yung Woo Shin South Korea 10 107 0.7× 68 0.6× 58 0.7× 180 2.4× 74 1.0× 51 456
Shaoxun Wang United States 17 247 1.7× 217 2.0× 38 0.5× 80 1.1× 175 2.3× 43 762
Yanxiao Xiang China 14 223 1.5× 120 1.1× 64 0.8× 16 0.2× 42 0.6× 21 575

Countries citing papers authored by Jin‐Min Guo

Since Specialization
Citations

This map shows the geographic impact of Jin‐Min Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin‐Min Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin‐Min Guo more than expected).

Fields of papers citing papers by Jin‐Min Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jin‐Min Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin‐Min Guo. The network helps show where Jin‐Min Guo may publish in the future.

Co-authorship network of co-authors of Jin‐Min Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Jin‐Min Guo. A scholar is included among the top collaborators of Jin‐Min Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jin‐Min Guo. Jin‐Min Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Anna, et al.. (2025). The risk of propofol infusion syndrome on epilepsy patients:Insights from FAERS data and published case reports. European Journal of Pharmacology. 999. 177429–177429. 2 indexed citations
2.
Wang, Lei, Xia Liu, Yan Chen, et al.. (2025). What drives hyperammonemic encephalopathy in AED users: monotherapy risks or polypharmacy perils?. Frontiers in Pharmacology. 16. 1477127–1477127.
3.
Li, Bing, et al.. (2025). Adverse events associated with inclisiran: a real-world pharmacovigilance study of FDA adverse event reporting system (FAERS). Expert Opinion on Drug Safety. 1–12. 1 indexed citations
4.
Jing, Kai, Feng Chen, Jingjing Wan, et al.. (2024). Orosomucoid 2 is an endogenous regulator of neuronal mitochondrial biogenesis and promotes functional recovery post-stroke. Pharmacological Research. 209. 107422–107422. 3 indexed citations
5.
Zhang, Zhihuan, Hao Jiang, Yu Zhao, et al.. (2024). Anti-hypertensives associated with survival in cancer patients receiving immunotherapy: new evidence from a real-world cohort study and meta-analysis. Therapeutic Advances in Medical Oncology. 16. 12736963–12736963. 1 indexed citations
6.
Jing, Kai, et al.. (2023). Dual effect of C–C motif chemokine receptor 5 on ischemic stroke: More harm than benefit?. European Journal of Pharmacology. 953. 175857–175857. 5 indexed citations
7.
Wang, Lei, Jia Wang, Shan Qing, Shu He, & Jin‐Min Guo. (2023). Involvement of baroreflex deficiency in the age-related loss of estrogen efficacy against cerebral ischemia. Frontiers in Aging Neuroscience. 15. 1167170–1167170. 4 indexed citations
8.
Tian, Wei, et al.. (2020). The discovery of novel small molecule allosteric activators of aldehyde dehydrogenase 2. European Journal of Medicinal Chemistry. 212. 113119–113119. 7 indexed citations
9.
Yu, Jian‐Guang, et al.. (2019). Anisodamine Ameliorates Hyperkalemia during Crush Syndrome through Estradiol-Induced Enhancement of Insulin Sensitivity. Frontiers in Pharmacology. 10. 1444–1444. 10 indexed citations
11.
Guo, Jin‐Min, et al.. (2017). SIRT1‐dependentAMPKpathway in the protection of estrogen against ischemic brain injury. CNS Neuroscience & Therapeutics. 23(4). 360–369. 51 indexed citations
12.
Li, Mu, Jin‐Min Guo, Xiaolan Xu, & Junming Wang. (2017). Diurnal macular choroidal area fluctuation in normal and primary open angle glaucoma groups. International Journal of Ophthalmology. 10(8). 1233–1238. 2 indexed citations
13.
Zhang, Enhui, Miao Wu, Jin‐Min Guo, et al.. (2016). Activation of α7 Nicotinic Acetylcholine Receptor Decreases On-site Mortality in Crush Syndrome through Insulin Signaling-Na/K-ATPase Pathway. Frontiers in Pharmacology. 7. 79–79. 17 indexed citations
14.
Guo, Jin‐Min, Aijun Liu, Pu Zang, et al.. (2013). ALDH2 protects against stroke by clearing 4-HNE. Cell Research. 23(7). 915–930. 152 indexed citations
15.
Liu, Aijun, Jin‐Min Guo, Wei Liu, et al.. (2013). Involvement of Arterial Baroreflex in the Protective Effect of Dietary Restriction Against Stroke. Journal of Cerebral Blood Flow & Metabolism. 33(6). 906–913. 20 indexed citations
16.
Guo, Jin‐Min, Aijun Liu, Pu Zang, et al.. (2013). Supplementary information, Figure S1. 1 indexed citations
17.
Guo, Jin‐Min, Wei Wang, Wei Guo, et al.. (2012). Involvement of Acetylcholine‐α7nAChR in the Protective Effects of Arterial Baroreflex against Ischemic Stroke. CNS Neuroscience & Therapeutics. 18(11). 918–926. 35 indexed citations
18.
Yu, Jian‐Guang, Shangqing Song, Hao Shu, et al.. (2011). Baroreflex deficiency hampers angiogenesis after myocardial infarction via acetylcholine- 7-nicotinic ACh receptor in rats. European Heart Journal. 34(30). 2412–2420. 45 indexed citations
19.
Guo, Jin‐Min, Aijun Liu, & Ding‐Feng Su. (2010). Genetics of stroke. Acta Pharmacologica Sinica. 31(9). 1055–1064. 28 indexed citations
20.
Guo, Jin‐Min, et al.. (2009). New strategies for the prevention of stroke. Clinical and Experimental Pharmacology and Physiology. 37(2). 265–271. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026